AGIOS PHARMACEUTICALS, INC. Annual Earnings Per Share, Basic in USD/shares from 2019 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Agios Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2019 to 2023.
  • Agios Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was 16.7 USD/shares.
  • Agios Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was 11.8 USD/shares.
  • Agios Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -6.33 USD/shares, a 49.6% decline from 2022.
  • Agios Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -4.23 USD/shares, a 116% decline from 2021.
  • Agios Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2021 was 26.6 USD/shares.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$6 -$2 -49.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 -$4 -$31 -116% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $26.60 +$31.30 Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 -$5 +$2.12 +30.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 -$7 Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.